用于抑制与氧化压力相关的视网膜退化症的probucol-LCA纳米颗粒的配方和评估

Susbin Raj Wagle1, Alicia Brunet2,3, Rebekah James2,3,4

  • 1The Biotechnology and Drug Development Research Laboratory, Curtin Medical School, Curtin Medical Research Institute, Curtin University, Bentley, Perth, Western Australia, 6102, Australia.

概括

新的纳米颗粒结合了probucol和石化酸 (LCA) 提供了针对性视网膜保护,防止氧化应激. 这些抗氧化纳米颗粒在临床前模型中显示出安全性和有效性,显示出治疗视力丧失疾病的潜力.